Respiratory infections multiplex, nucleic acid detection

Scheme information

Service

EQAS

Scheme

Respiratory infections multiplex, nucleic acid detection

Service provider

Labquality

Accreditation

Not accredited

Status

New scheme in 2018

Target

Laboratories

Coverage

Analytical phase

Rounds

2

Distributions

Europe, the Middle East and Asia

Coordinator

Jaana Paakkanen

Expert

Matti Waris

Products

5300 / Respiratory infections multiplex, nucleic acid detection

Samples: 4 simulated samples, ≥ 0.5mL each

Type: Physical

Examinations: Direct multiplex nucleic acid detection. Pathogens included are C. pneumoniae, M. pneumoniae, B. pertussis, B. parapertussis, influenza A/B, RSV A/B, human rhinovirus, enterovirus, parainfluenza, human metapneumovirus, adenovirus and coronavirus.

Additional information: Pathogens are covered during annual scheme: participation to all rounds required

Search other products Show similar products

Pin It on Pinterest

Share This